Your browser doesn't support javascript.
loading
Rationale and design of the OPTIMIZE trial: OPen label multicenter randomized trial comparing standard IMmunosuppression with tacrolimus and mycophenolate mofetil with a low exposure tacrolimus regimen In combination with everolimus in de novo renal transplantation in Elderly patients.
de Boer, S E; Sanders, J S F; Bemelman, F J; Betjes, M G H; Burgerhof, J G M; Hilbrands, L; Kuypers, D; van Munster, B C; Nurmohamed, S A; de Vries, A P J; van Zuilen, A D; Hesselink, D A; Berger, S P.
Afiliación
  • de Boer SE; Department of Internal Medicine, Division of Nephrology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands. s.e.de.boer@umcg.nl.
  • Sanders JSF; Department of Internal Medicine, Division of Nephrology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
  • Bemelman FJ; Department of Internal Medicine, Division of Nephrology, Amsterdam Universal Medical Center, Amsterdam, The Netherlands.
  • Betjes MGH; Department of Internal Medicine, Division of Nephrology & Transplantation, Erasmus MC, Erasmus University Medical Center, Rotterdam, The Netherlands.
  • Burgerhof JGM; Department of Epidemiology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
  • Hilbrands L; Department of Internal Medicine, Division of Nephrology, Radboud University Medical Center, Nijmegen, The Netherlands.
  • Kuypers D; Department of Nephrology and Renal Transplantation, University Hospitals Leuven, Leuven, Belgium.
  • van Munster BC; Department of Internal Medicine, Divison of Geriatrics, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
  • Nurmohamed SA; Department of Internal Medicine, Division of Nephrology, Amsterdam Universal Medical Center, Amsterdam, The Netherlands.
  • de Vries APJ; Department of Internal Medicine, Division of Nephrology; and Leiden Transplant Center, Leiden University Medical Center, Leiden University, Leiden, The Netherlands.
  • van Zuilen AD; Department of Internal Medicine, Division of Nephrology, University Medical Center Utrecht, Utrecht, The Netherlands.
  • Hesselink DA; Department of Internal Medicine, Division of Nephrology & Transplantation, Erasmus MC, Erasmus University Medical Center, Rotterdam, The Netherlands.
  • Berger SP; Department of Internal Medicine, Division of Nephrology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
BMC Nephrol ; 22(1): 208, 2021 06 02.
Article en En | MEDLINE | ID: mdl-34078323
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Trasplante de Riñón / Tacrolimus / Inhibidores de la Calcineurina / Everolimus / Inmunosupresores / Ácido Micofenólico Tipo de estudio: Clinical_trials Aspecto: Patient_preference Límite: Aged / Humans Idioma: En Revista: BMC Nephrol Asunto de la revista: NEFROLOGIA Año: 2021 Tipo del documento: Article País de afiliación: Países Bajos Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Trasplante de Riñón / Tacrolimus / Inhibidores de la Calcineurina / Everolimus / Inmunosupresores / Ácido Micofenólico Tipo de estudio: Clinical_trials Aspecto: Patient_preference Límite: Aged / Humans Idioma: En Revista: BMC Nephrol Asunto de la revista: NEFROLOGIA Año: 2021 Tipo del documento: Article País de afiliación: Países Bajos Pais de publicación: Reino Unido